APA

Cameron D. A., Anderson A., Toy E., Evans T. R. J., Le Vay J. H., Kennedy I. C. S., Grieve R. J., Perren T. J., Jones A., Mansi J., Crown J. & Leonard R. C. F. (20030107). Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?. : British journal of cancer.

Chicago

Cameron D A, Anderson A, Toy E, Evans T R J, Le Vay J H, Kennedy I C S, Grieve R J, Perren T J, Jones A, Mansi J, Crown J and Leonard R C F. 20030107. Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?. : British journal of cancer.

Harvard

Cameron D. A., Anderson A., Toy E., Evans T. R. J., Le Vay J. H., Kennedy I. C. S., Grieve R. J., Perren T. J., Jones A., Mansi J., Crown J. and Leonard R. C. F. (20030107). Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?. : British journal of cancer.

MLA

Cameron D A, Anderson A, Toy E, Evans T R J, Le Vay J H, Kennedy I C S, Grieve R J, Perren T J, Jones A, Mansi J, Crown J and Leonard R C F. Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?. : British journal of cancer. 20030107.